Browse studies

Find your next paid study

25,415 recruiting studies available now

Differentiating the Effects of Long-acting Bronchodilators Administered by Nebulizer Versus Dry Powder Inhaler in Symptomatic Patients With Chronic Obstructive Pulmonary Disease

The purpose of this study is to compare the effectiveness of inhaled bronchodilators delivered via nebulizers vs. dry powder inhalers (DPIs) in symptomatic par…

COPD (Chronic Obstructive Pulmonary Disease)

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of Tennessee Graduate School of MedicineNCT07133880

Phase 4

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Each of Two Dose Levels of Sarilumab in Adults With Early Polymyalgia Rheumatica

This is a randomized, double-blind, placebo-controlled, parallel-group, Phase 4, 3-group study to assess whether treatment with sarilumab at either 150 mg q2w …

Polymyalgia Rheumatica

Estimated

~$25 – $1,500

Actual pay is set by the research site.

SanofiNCT07286214

Phase 1

Phase I/II Trial of Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

Background: Myelodysplastic syndrome (MDS) and myelodysplastic/myeloproliferative neoplasm (MDS/MPN) are blood disorders that can cause serious complications …

Myelodysplastic Syndromes

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06303193

Observational

A Pilot Study for Developing a Comprehensive Signal Detection Approach for the Mechanisms of Action and Analgesic Efficacy of Two Analgesics Using Human Experimental Models of Pain (HEMP)

This pilot study will test an innovative way to establish how pain medicines provide analgesia in healthy adults. The study uses a group of short, controlled p…

Acute Pain

Estimated

~$10 – $1,125

Actual pay is set by the research site.

National Center for Complementary and Integrative Health (NCCIH)NCT07549490

Observational

Transcranial Magnetic Stimulation to Augment Exposure and Response Prevention for Pediatric OCD

The goal of this clinical trial is to test transcranial magnetic stimulation (TMS) for improving the outcomes of Exposure with Response Prevention (ERP) in you…

Obsessive Compulsive Behavior

Estimated

~$10 – $750

Actual pay is set by the research site.

Bradley HospitalNCT07859683

Phase 1

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

Protocol # 000860 Background: Diffuse gliomas are tumors that affect the brain and spinal cord. Gliomas that develop in people with certain gene mutations (I…

Brain TumorCancer

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT05588141

Phase 2

A Double-blind, Randomized, Placebo-controlled Proof oF Concept Clinical Study to Evaluate the Safety, Pharmacokinetics, AND Pharmacodynamics of Vaginal AZU-101 (Lasofoxifene Tartrate) in Postmenopausal Women

Study Objectives: Primary: • To assess the safety, tolerability, and systemic pharmacokinetics (PK) of AZU-101 Secondary: • To evaluate efficacy of daily v…

Vulvo Vaginal Atrophy (VVA)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Azure Biotech Inc.NCT06197568

Observational

Pivotal Randomized Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients und…

Coronary Artery DiseaseHigh Risk Percutaneous Coronary InterventionInterventional Cardiology+1 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Supira MedicalNCT07296744

Phase 2

Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Omega-3 Fatty Acid (O3FA) Supplementation for Adult and Juvenile Dermatomyositis (DM/JDM)

Dermatomyositis (DM) is a rare autoimmune disease that causes muscle weakness, skin rashes, and other symptoms. Researchers think both genetic and environmenta…

Dermatomyositis (DM)Juvenile Dermatomyositis (JDM)

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Institute of Environmental Health Sciences (NIEHS)NCT07111065

Phase 3

Metformin (Dimethylbiguanide) and Insulin Resistance in Women Completing Neoadjuvant and/or Adjuvant Cytotoxic Treatment of Stage I-III Breast Cancer

This phase III trial evaluates how often women develop insulin resistance and type-2 diabetes and compares metformin with usual care to usual care alone in tre…

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+1 more

Estimated

~$50 – $1,500

Actual pay is set by the research site.

City of Hope Medical CenterNCT06763328

Observational

Geriatric Assessment (GA)-Driven Interventions With Supportive Care (The GAIN-S Trial): Telemedicine to Increase Goal Concordant Care for Older Adults With Cancer in the Community

This clinical trial evaluates whether geriatric assessment-driven interventions with supportive care (GAIN-S) using telemedicine can be used to identify areas …

Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm

Estimated

~$10 – $750

Actual pay is set by the research site.

City of Hope Medical CenterNCT06022965

Phase 3

A Multi-centre, Randomised, Double-blind, Placebo-controlled, Phase IIIb Trial to Evaluate the Effect of Survodutide on Cardiac Structure and Function of Participants With Overweight or Obesity and Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD); (ELEVATE-LIVER)

This study is for adults aged 18 years and older who have a type of fatty liver disease called metabolic dysfunction-associated steatotic liver disease (MASLD)…

ObesityMetabolic Dysfunction-associated Steatotic Liver Disease

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Boehringer IngelheimNCT07850063